EUVIMEDEUVIMED entdecken
Crossref

Allergy Misinformation Across Social Media Platforms: Content Analysis and Public Response

Udain Khadija, Sabina Vohra-Miller, Samira Jeimy

The Journal of Allergy and Clinical Immunology: In Practice · 2026

DOI: 10.1016/j.jaip.2025.12.032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2026. Verfasst von Udain Khadija und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Immunology and Allergy, Department of Medicine, Western University, London, Ontario, Canada. Hauptthemen laut MEDLINE: Social Media, Communication, Hypersensitivity. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Allergy-related misinformation proliferates across social media platforms, potentially compromising evidence-based patient care, yet comprehensive analyses remain limited. OBJECTIVE: To characterize dominant themes, engagement patterns, and public responses to allergy misinformation across major social media platforms. METHODS: We conducted cross-sectional qualitative content analysis of publicly available posts containing allergy misinformation from TikTok, Instagram, Facebook, and X between January and March 2025. Posts with 500 or more interactions were identified using systematic key word searches and coded for misinformation themes by independent reviewers. Public sentiment was assessed through analysis of top-ranked comments. RESULTS: Among 347 analyzed posts with 12.3 million combined views, natural cure promotion was most prevalent (31%), followed by IgG testing endorsement (24%), medication fearmongering (18%), food allergy misrepresentation (16%), and pharmaceutical conspiracy theories (11%). Natural cure content generated the highest engagement (median, 2,847 interactions; P < .001). Visual platforms (TikTok and Instagram) favored natural cures whereas text-based platforms emphasized conspiracy content. Of 3,470 analyzed comments, 62% were supportive or neutral toward misinformation, with only 38% providing challenged responses. Among corrective comments, only 23% included scientific evidence. CONCLUSIONS: Allergy misinformation achieves high engagement with limited public correction across social media platforms. Health care providers must anticipate IgG testing and natural remedy narratives, integrate myth-busting into counseling, and leverage society-led digital strategies to counter misinformation's influence on clinical care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Social MediaCommunicationHypersensitivityHumansCross-Sectional StudiesDigital MediaMedia Exposure

Stichwörter der Autor:innen

AllergyDigital health literacyHealth communicationIgG testingMedication adherenceMisinformationNatural remediesPatient educationPublic healthSocial media

Autor:innen und Institutionen

  • Division of Clinical Immunology and Allergy, Department of Medicine, Western University, London, Ontario, Canada.
  • Division of Clinical Immunology and Allergy, Department of Medicine, Western University, London, Ontario, Canada. Electronic address: samira.jeimy@lhsc.on.ca.

Zitieren

APA

Khadija, U., Vohra-Miller, S., & Jeimy, S. (2026). Allergy Misinformation Across Social Media Platforms: Content Analysis and Public Response. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2025.12.032

Vancouver

Khadija U, Vohra-Miller S, Jeimy S. Allergy Misinformation Across Social Media Platforms: Content Analysis and Public Response. The Journal of Allergy and Clinical Immunology: In Practice. 2026. doi:10.1016/j.jaip.2025.12.032

BibTeX
@article{Khadija2026,
  author = {Khadija, Udain and Vohra-Miller, Sabina and Jeimy, Samira},
  title = {Allergy Misinformation Across Social Media Platforms: Content Analysis and Public Response},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2026},
  doi = {10.1016/j.jaip.2025.12.032}
}
Kostenlos starten →